General practices and allergy clinics across Australia are invited to take part in a new clinical trial aiming to improve the lives of young people with hay fever, our country’s most common allergic disease.  Recruitment sites in every state and territory have partnered with the National Allergy Centre of Excellence (NACE), hosted at Murdoch Children’s Research Institute (MCRI), to launch the ARISE Trial.

The clinical trial is seeking 14 to 29 year olds with hay fever, with participants to follow a specifically designed education package alongside their daily nasal spray. The trial will explore whether they experience less symptoms and have better quality of life.

Register your interest here if you are interested in becoming a recruitment site. 

A new trial aims to reduce allergic rhinitis (hay fever) symptoms and improve the quality of life of people with hay fever, the country’s most common allergic disease for young Australians.

If successful, the trial will change the way hay fever is managed, reducing the burden on those living with the disease, their families and the healthcare system
A new trial is aiming to reduce symptoms and improve the quality of life of young Australians with hay fever, the country’s most common allergic disease.

This news item was issued on 20 March 2025 by Jill Smith, CEO of of ASCIA, the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand.